CAS RN: 25756-29-0
1-cyclohexyl-N-methyl-methanamine
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20260623
100mg / 250mg / 1g
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 25756-29-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
25756-29-0 / 1-cyclohexyl-N-methylmethanamine
Standard CAS: 25756-29-0
Multi CAS: No
Basic Information
copy
CAS
25756-29-0 copy
Multi CAS
No copy
Molecular Formula
C8H17N copy
Molecular Weight
127.230000 copy
Exact Mass
127.136100 copy
SMILES
CNCC1CCCCC1 copy
InChI
InChI=1S/C8H17N/c1-9-7-8-5-3-2-4-6-8/h8-9H,2-7H2,1H3 copy
InChIKey
IWHLPMBLJZJCJK-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Fraction Csp3
1 copy
Rotatable bonds
2 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
40.5 copy
TPSA
12.03 copy
LogP / Solubility
WLOGP
1.79 copy
MLOGP
1.56 copy
XLogP3
2.2 copy
Consensus LogP
1.85 copy
Log S (ESOL)
-1.62 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.89 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-2.21 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.23 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy